1020720-04-0

1020720-04-0 structure

Name: Zonisamide-d4
Chemical Name: (4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide
CAS Number: 1020720-04-0
Molecular Formula: C₈H₄D₄N₂O₃S
Molecular Weight: 216.25000
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Calcium Channel
Create Date: 2016-12-20 15:11:31
Modify Date: 2024-01-10 17:51:52
Zonisamide-d4 (AD 810-d4) is the deuterium labeled Zonisamide. Zonisamide (AD 810) is an inhibitor of zinc enzyme carbonic anhydrase (CA), with Kis of 35.2 nM and 20.6 nM for human mitochondrial isozyme hCA II and hCA V, respectively. Zonisamide has antiepileptic activity. Zonisamide can be used for the rsearch for epilepsy, seizures and Parkinson's disease[1][2].

Name	(4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide
Synonyms	Excegran-d4 Zonegran-d4 1,2-(Benzisoxazole-d4)-3-methanesulfonamide AD 810-d4 Zonisamide-d4 Aleviatin-d4 3-(Sulfamoylmethyl)-1,2-benzisoxazole-d4

Description	Zonisamide-d4 (AD 810-d4) is the deuterium labeled Zonisamide. Zonisamide (AD 810) is an inhibitor of zinc enzyme carbonic anhydrase (CA), with Kis of 35.2 nM and 20.6 nM for human mitochondrial isozyme hCA II and hCA V, respectively. Zonisamide has antiepileptic activity. Zonisamide can be used for the rsearch for epilepsy, seizures and Parkinson's disease[1][2].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Signaling Pathways >> Metabolic Enzyme/Protease >> Carbonic Anhydrase Research Areas >> Neurological Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Peters DH, et al. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs. 1993 May;45(5):760-87. [3]. Giuseppina De Simone, et al. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett. 2005 May 2;15(9):2315-20.

Molecular Formula	C₈H₄D₄N₂O₃S
Molecular Weight	216.25000
Exact Mass	216.05100
PSA	94.57000
LogP	2.39740

1020720-04-0	68291-98-5
1435934-68-1	1217201-89-2
1076199-51-3	68291-97-4
1188265-58-8	1185240-22-5
2070014-84-3	2714473-10-4